Investor
The company's technology uses machine learning to identify any major changes in patients' vitals.
The Series A funding will continue to fuel the European startup's push into global markets.
The Series C funding will support a service expansion beyond California's major metro areas, and support for new products.
During December, we’ll interview thought leaders and experts to determine how data is redesigning the roles of CEOs, CFOs, COOs and other execs.
The Finnish company now enjoys support from several tech founders, athletes, and celebrities.
The company will use the new funding to grow its US team and scale its commercial operations.
The Cedars-Sinai accelorator alumnus plans to use the money to grow its workforce and launch new engagement functionality.
As part of the deal Tabula Rasa will acquire the DoseMeRx platform, which gives clinicians information about how a patient will metabolize and absorb certain medications.
ResMed is expected to close the $225M deal to purchase the smart inhaler company by March 2019.
The health startups use AI to tackle a range of problems including malaria, addiction and diabetes.